MedTrace Logo

Comparison of Warfarin Dosing Using Decision Model Versus Pharmacogenetic Algorithm

NCT00511173 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2012-12-11

Study results available
· View outcomes & findings →

Summary

This is a prospective comparison of clinician dosing and a pharmacogenetic algorithm in diagnosed patients requiring warfarin therapy.

Conditions

Interventions

GENETIC

Warfarin Dose based on pharmacogenetics

Warfarin dose adjustment will be based on the standard clinician dosing compared to the use of the pharmacogenetic base algorithm

Sponsors & Collaborators

  • Creighton University

    lead OTHER

Principal Investigators

  • Christopher J. Destache, Pharm. D. · Creighton University

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-08-31
Primary Completion
2008-11-30
Completion
2008-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00511173 on ClinicalTrials.gov